Is The Medical Device Review System Flawed?

Law360, New York (August 01, 2011, 1:14 PM ET) -- At the request of the United States Food and Drug Administration, the Institute of Medicine appointed a committee to review the process under which medical devices are analyzed for reasonable assurances of safety and effectiveness as required by the Federal Food, Drug and Cosmetic Act (FFDCA). Manufacturers of medical devices that may have a moderate risk to patients cannot market the devices until the devices make their way through the 510(k) process — a reference to Section 510(K) of the FFDCA.

Due to growing concerns of...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required